119 related articles for article (PubMed ID: 30774100)
1. Introduction of routine hepatitis B screening for all patients receiving cancer treatment.
Leber K; Otten JMMB; Depla ACTM; Brandjes DPM; Lauw FN
Neth J Med; 2019 Jan; 77(1):19-24. PubMed ID: 30774100
[TBL] [Abstract][Full Text] [Related]
2. Low rates of hepatitis B virus screening at the onset of chemotherapy.
Hwang JP; Fisch MJ; Zhang H; Kallen MA; Routbort MJ; Lal LS; Vierling JM; Suarez-Almazor ME
J Oncol Pract; 2012 Jul; 8(4):e32-9. PubMed ID: 23180996
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of prophylactic antiviral therapy and outcomes in HBsAg-negative, anti-HBc-positive patients receiving chemotherapy: a real-life experience.
Papadopoulos N; Deutsch M; Manolakopoulos S; Bitsi C; Michalakeas H; Poulakidas H; Tsironi E; Giannouli S; Papatheodoridis GV; Koskinas J; Pectasides D
Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):56-60. PubMed ID: 27669175
[TBL] [Abstract][Full Text] [Related]
4. Screening rate for hepatitis B virus infection in patients undergoing chemotherapy in Japan.
Ikeda M; Yamamoto H; Kaneko M; Oshima H; Takahashi H; Umemoto K; Watanabe K; Hashimoto Y; Ohno I; Mitsunaga S; Okusaka T
Int J Clin Oncol; 2016 Dec; 21(6):1162-1166. PubMed ID: 27260010
[TBL] [Abstract][Full Text] [Related]
5. Universal hepatitis B screening and management in patients with cancer who received immunosuppressive chemotherapy.
Thompson LA; Heath LJ; Freml H; Delate T
J Oncol Pharm Pract; 2020 Jul; 26(5):1141-1146. PubMed ID: 31789111
[TBL] [Abstract][Full Text] [Related]
6. Low level of hepatitis B virus screening among patients receiving chemotherapy.
Wi CI; Loo NM; Larson JJ; Moynihan TJ; Madde NR; Grendahl DC; Alberts SR; Kim WR
Clin Gastroenterol Hepatol; 2015 May; 13(5):970-5; quiz e51. PubMed ID: 25460017
[TBL] [Abstract][Full Text] [Related]
7. Screening for viral hepatitis prior to rituximab chemotherapy.
Leonard AN; Love BL; Norris LB; Siddiqui SK; Wallam MN; Bennett CL
Ann Hematol; 2016 Jan; 95(1):27-33. PubMed ID: 26382277
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus reactivation during anti-cancer chemotherapy in patients with past hepatitis B virus infection.
Kim E; Yune S; Ha JM; Lee WJ; Hwang JW; Paik YH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Hepatogastroenterology; 2014 Sep; 61(134):1704-11. PubMed ID: 25436366
[TBL] [Abstract][Full Text] [Related]
9. Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis.
Koo YX; Tay M; Teh YE; Teng D; Tan DS; Tan IB; Tai DW; Quek R; Tao M; Lim ST
Ann Hematol; 2011 Oct; 90(10):1219-23. PubMed ID: 21520001
[TBL] [Abstract][Full Text] [Related]
10. Clinical practice of hepatitis B screening in patients starting with chemotherapy: A survey among Dutch oncologists.
Leber K; Otten HJMMB; Brandjes DPM; Claassen MAA; Lauw FN
Eur J Cancer Care (Engl); 2021 Nov; 30(6):e13495. PubMed ID: 34310787
[TBL] [Abstract][Full Text] [Related]
11. Practice Patterns in Hepatitis B Virus Screening Before Cancer Chemotherapy in a Major US Hospital Network.
Kwak YE; Stein SM; Lim JK
Dig Dis Sci; 2018 Jan; 63(1):61-71. PubMed ID: 29177849
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus reactivation in patients with resolved hepatitis B virus infection receiving chemotherapy or immunosuppressive therapy.
Su YC; Lin PC; Yu HC; Wu CC
Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):925-929. PubMed ID: 29621049
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B Virus Reactivation in the Setting of Cancer Chemotherapy and Other Immunosuppressive Drug Therapy.
Gonzalez SA; Perrillo RP
Clin Infect Dis; 2016 Jun; 62 Suppl 4(Suppl 4):S306-13. PubMed ID: 27190320
[TBL] [Abstract][Full Text] [Related]
14. A Hospital-Based Analysis in the Department of Clinical Chemistry for the Patients with HBV Reactivation after Anti-Cancer or Immunosuppressive Therapy.
Matsuzaki T; Ohkubo K; Yuki M; Kawashima H; Matsunaga A
Rinsho Byori; 2015 Mar; 63(3):297-304. PubMed ID: 26524851
[TBL] [Abstract][Full Text] [Related]
15. Electronic Alert System Significantly Increases HBV Screening Rates Before Immunosuppressive Treatments.
Köksal AŞ; Toka B; Sadeçolak M; Acar Ş; Eminler AT; Tozlu M; Karabay O
Turk J Gastroenterol; 2023 May; 34(5):552-559. PubMed ID: 36939611
[TBL] [Abstract][Full Text] [Related]
16. Rare clinically significant hepatic events and hepatitis B reactivation occur more frequently following rather than during direct-acting antiviral therapy for chronic hepatitis C: Data from a national US cohort.
Serper M; Forde KA; Kaplan DE
J Viral Hepat; 2018 Feb; 25(2):187-197. PubMed ID: 28845882
[TBL] [Abstract][Full Text] [Related]
17. Prophylaxis against chemotherapy-induced reactivation of hepatitis B virus infection with Lamivudine.
Simpson ND; Simpson PW; Ahmed AM; Nguyen MH; Garcia G; Keeffe EB; Ahmed A
J Clin Gastroenterol; 2003 Jul; 37(1):68-71. PubMed ID: 12811213
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice.
Loggi E; Gitto S; Galli S; Minichiello M; Conti F; Grandini E; Scuteri A; Vitale G; Di Donato R; Cursaro C; Furlini G; Andreone P
J Clin Virol; 2017 Aug; 93():66-70. PubMed ID: 28654775
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B Reactivation in a Patient Receiving Chemotherapy for Breast Cancer: A Case Report.
Remo M; Abraham I; Kankanala V; Chacra W; Danciu OC
Anticancer Res; 2017 Jul; 37(7):3791-3793. PubMed ID: 28668876
[TBL] [Abstract][Full Text] [Related]
20. Reactivation of hepatitis B virus in patients with undetectable HBsAg undergoing chemotherapy for malignant lymphoma or multiple myeloma.
Matsui T; Kang JH; Nojima M; Tomonari A; Aoki H; Yamazaki H; Yane K; Tsuji K; Andoh S; Andoh S; Sakai H; Maemori M; Maguchi H; Tanaka Y
J Med Virol; 2013 Nov; 85(11):1900-6. PubMed ID: 23926082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
